ATE143260T1 - Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen - Google Patents

Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen

Info

Publication number
ATE143260T1
ATE143260T1 AT91403169T AT91403169T ATE143260T1 AT E143260 T1 ATE143260 T1 AT E143260T1 AT 91403169 T AT91403169 T AT 91403169T AT 91403169 T AT91403169 T AT 91403169T AT E143260 T1 ATE143260 T1 AT E143260T1
Authority
AT
Austria
Prior art keywords
anesthesia
desflurane
isoflurane
medicinal preparations
disclosed
Prior art date
Application number
AT91403169T
Other languages
English (en)
Inventor
James W Young
Steven Brandt
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of ATE143260T1 publication Critical patent/ATE143260T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT91403169T 1990-11-29 1991-11-22 Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen ATE143260T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/619,780 US5114715A (en) 1990-11-29 1990-11-29 Methods of use and compositions of (s)-isoflurane and (s)-desflurane

Publications (1)

Publication Number Publication Date
ATE143260T1 true ATE143260T1 (de) 1996-10-15

Family

ID=24483269

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91403169T ATE143260T1 (de) 1990-11-29 1991-11-22 Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen

Country Status (5)

Country Link
US (1) US5114715A (de)
EP (1) EP0491586B1 (de)
JP (1) JPH05186339A (de)
AT (1) ATE143260T1 (de)
DE (1) DE69122364T2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283372A (en) * 1991-12-04 1994-02-01 Anaquest, Inc. Preparation of purified optical isomers of desflurane
US5331000A (en) * 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
CA2139638A1 (en) * 1992-07-07 1994-01-20 Nancy M. Gray Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
AU4770593A (en) * 1992-07-07 1994-01-31 Sepracor, Inc. Methods of using (+) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
CA2147357A1 (en) * 1992-11-04 1994-05-11 Nancy M. Gray Methods and compositions (+) doxazosin for the treatment of hypertension
US5443824A (en) * 1994-03-14 1995-08-22 Piacquadio; Daniel J. Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions
GB9418532D0 (en) * 1994-09-14 1994-11-02 Univ Aberdeen Anaesthetic gas mixtures
US5739151A (en) * 1996-07-19 1998-04-14 Sepracor Inc. Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
US20030200963A1 (en) * 1998-01-09 2003-10-30 Flament-Garcia Mary Jane Container for an inhalation anesthetic
US6162443A (en) * 1998-01-09 2000-12-19 Abbott Laboratories Container for an inhalation anesthetic
US6074668A (en) * 1998-01-09 2000-06-13 Abbott Laboratories Container for an inhalation anesthetic
US6083514A (en) * 1998-01-09 2000-07-04 Abbott Laboratories Polymethylpentene container for an inhalation anesthetic
NZ555173A (en) * 2004-11-17 2010-04-30 Piramal Critical Care Inc Process for producing desflurane from isoflurane with antimony pentafluoride and HF
EP2081562B1 (de) 2006-09-20 2016-02-24 The Board of Regents of The University of Texas System Verfahren zur abgabe von flüchtigen anästhetika für die regionalanästhesie und/oder schmerzlinderung
PL2244783T3 (pl) 2008-01-22 2020-08-24 Board Of Regents, The University Of Texas System Kompozycje lotnego anestetyku i sposoby stosowania
JP2012526133A (ja) 2009-05-05 2012-10-25 ベイポジェニックス インコーポレイテッド 炎症を低減させるための新規揮発性麻酔薬製剤およびその使用法
JP4991834B2 (ja) * 2009-12-17 2012-08-01 シャープ株式会社 車両用前照灯
US9968540B2 (en) 2011-06-24 2018-05-15 Vapogenix, Inc. Formulations and methods for treating dermatological disorders or diseases
CN113712911A (zh) 2013-03-15 2021-11-30 维普詹尼克斯公司 新型镇痛组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3469011A (en) * 1966-10-03 1969-09-23 Air Reduction 1,1,2-trifluoro-2-chloroethyl-difluoromethyl ether as an anesthetic agent
US3535388A (en) * 1969-05-12 1970-10-20 Air Reduction 1-chloro-2,2,2-trifluoroethyl difluoromethyl ether
US3897502A (en) * 1971-10-22 1975-07-29 Airco Inc Process for making fluorinated ethers
DE2340560C2 (de) * 1973-08-10 1982-12-16 Hoechst Ag, 6000 Frankfurt 1.2.2.2-Tetrafluoräthyl-äther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltendes Inhalations-Anästhetikum
DE2340561C2 (de) * 1973-08-10 1982-12-16 Hoechst Ag, 6000 Frankfurt 2.2.2-Trifluor-1-chloräthyl-äther und Verfahren zu ihrer Herstellung sowie Inhalations-Anästhetikum, das einen dieser Stoffe enthält
US3970710A (en) * 1975-04-09 1976-07-20 Abbott Laboratories Process for making trifluoroethanol
DE2656545A1 (de) * 1976-12-14 1978-06-15 Hoechst Ag Polyhalogenierte alpha, alpha'-difluordialkylaether und verfahren zu ihrer herstellung
US4220664A (en) * 1979-01-29 1980-09-02 The Dow Chemical Company Deuterated isoflurane as an anesthetic agent
US4273947A (en) * 1979-01-31 1981-06-16 Allied Chemical Corporation Hydrogenation of fluorine-containing carboxylic acids
US4262144A (en) * 1979-10-25 1981-04-14 The Dow Chemical Company Deuterated isoflurane
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
US4590310A (en) * 1984-08-02 1986-05-20 The Boc Group, Inc. Process for the preparation of 2,2,2-trifluoroethanol
US4762856A (en) * 1987-02-02 1988-08-09 Boc, Inc. Anesthetic composition and method of using the same
US4855511A (en) * 1988-07-18 1989-08-08 Boc, Inc. Process for preparing CHF2 OCHFCF3 and CHF2 OCHClCF3 and novel intermediate compounds employed therein

Also Published As

Publication number Publication date
DE69122364D1 (de) 1996-10-31
US5114715A (en) 1992-05-19
EP0491586B1 (de) 1996-09-25
JPH05186339A (ja) 1993-07-27
EP0491586A1 (de) 1992-06-24
DE69122364T2 (de) 1997-03-13

Similar Documents

Publication Publication Date Title
DE69122364D1 (de) Verwendung von (S)-Isofluran und (S)-Desfluran zur Anästhesie sowie entsprechende Arzneimittelzubereitungen
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE3855113D1 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE111733T1 (de) Verwendung von nikotin zur herstellung eines kit zur behandlung von krankheitszuständen, die auf eine nikotinbehandlung ansprechen.
DK1201241T3 (da) Sammensætninger indeholdende capsaicin eller capsaicinanaloge og et bedøvelsesmiddel
DE59109222D1 (de) Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
ATE297726T1 (de) Forskolin zur entwicklung magerer körpermasse
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
SE8102193L (sv) Terapeutiskt aktiv organisk forening och dess anvendning
DE69214467D1 (de) Verwendung von Thiazolidin-4-carboxylatderivaten zur Behandlung von Lungenerkrankungen
DE69841279D1 (de) Verwendung von humanem Parathyroid-hormon
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE3850154D1 (de) Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression.
DE69420776D1 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
ATE307203T1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
DK84181A (da) Derivater af 3,4,5-trihydroxypiperidin,fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler samt til dyreernaering
ATE108658T1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DE3781488D1 (de) Pharmazeutische zusammensetzung, enthaltend 2',3'-dideoxycytidin-2'-en(2',3'-dideoxy-2',3'-didehydrocytidin) zur behandlung von mit retrovirus infizierten patienten.
ATE125709T1 (de) Verwendung von ifn-gamma zur herstellung einer pharmazeutischen zusammensetzung für die behandlung von atl.
DE69301750D1 (de) Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
ATE194076T1 (de) Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties